TYNDALL CAPITAL PARTNERS L P - ONCONOVA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
TYNDALL CAPITAL PARTNERS L P ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$4,953,000
+182.9%
12,244,080
+483.9%
71.91%
+57.7%
Q1 2018$1,751,000
+17.0%
2,097,022
+110.3%
45.59%
+5.9%
Q4 2017$1,496,000
-12.3%
997,0220.0%43.06%
+97.6%
Q3 2017$1,705,000
-20.8%
997,0220.0%21.79%
-14.5%
Q2 2017$2,154,000
+36.1%
997,022
+91.4%
25.49%
-44.0%
Q1 2017$1,583,000
+33.9%
520,8320.0%45.53%
+9.9%
Q4 2016$1,182,000
-18.7%
520,8320.0%41.42%
-47.4%
Q3 2016$1,453,000520,83278.80%
Other shareholders

There were no reported owners of ONCONOVA THERAPEUTICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of ONCONOVA THERAPEUTICS INC shareholders